Ye Guo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Top Venues

Therapeutic advances in medical oncology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yunpeng Yang, Jianji Pan, Nianyong Chen, Ye Guo, Xiaoming Huang, Yanjie Wu, Shiangjiin Leaw, Fan Bai, Yu Wang, Na Zhao, Boxiong Tang, Gisoo Barnes
Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer. Head & neck (2024)
Junli Xue, Liqiong Xue, Wenbo Tang, Xiaoxiao Ge, Wei Zhao, Qun Li, Wei Peng, Congqi Dai, Ye Guo, Jin Li
TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study. Therapeutic advances in medical oncology 16 (2024)
Yunpeng Yang, Jianji Pan, Nianyong Chen, Ye Guo, Xiaoming Huang, Yanjie Wu, Shiangjiin Leaw, Fan Bai, Yu Wang, Na Zhao, Boxiong Tang, Gisoo Barnes
Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer. Head & neck 46 (9) (2024)
Junli Xue, Liqiong Xue, Wenbo Tang, Xiaoxiao Ge, Wei Zhao, Qun Li, Wei Peng, Congqi Dai, Ye Guo, Jin Li
TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study. Therapeutic advances in medical oncology 16 (2024)
Yunpeng Yang, Jianji Pan, Nianyong Chen, Ye Guo, Xiaoming Huang, Yanjie Wu, Shiangjiin Leaw, Fan Bai, Yu Wang, Na Zhao, Boxiong Tang, Gisoo Barnes
Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer. Head & neck 46 (9) (2024)
Yuxiang Ma, Jinhui Xue, Yuanyuan Zhao, Yang Zhang, Yan Huang, Yunpeng Yang, Wenfeng Fang, Ye Guo, Qun Li, Xiaoxiao Ge, Jie Sun, Bangyong Zhang, Yuhan Zhang, Jinyuan Xiao, Li Zhang, Hongyun Zhao
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors. Journal for immunotherapy of cancer 11 (6) (2023)
Shun Lu, Xiangqian Zheng, Yuping Sun, Dingzhi Huang, Lin Wu, Qinghai Ji, Chengzhi Zhou, Jianying Zhou, Ye Guo, Minghua Ge, Ding Ding, Jingxin Shao, Wanli Zhang, Ming Gao, Ying Cheng
Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer, and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial. Therapeutic advances in medical oncology 15 (2023)
Yi-Zhen Liu, Liqiong Xue, Zuguang Xia, Qunling Zhang, Ye Guo
Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study. Head & neck 44 (9) (2022)
Ye Guo
Therapy of head and neck cancer in China: Introduction to the special issue. Head & neck 44 (9) (2022)